ISIS Headboxes, ISIS Neurostimulator, ISIS Xpert Plus, ISIS Xpert, ISIS Xpress
inomed Medizintechnik GmbH · Decision date Sep 24, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 24, 2026 for K263010, a 510(k) premarket notification from inomed Medizintechnik GmbH covering ISIS Headboxes, ISIS Neurostimulator, ISIS Xpert Plus, ISIS Xpert and ISIS Xpress. The listed classification is an electrical evoked-response stimulator, product code GWF, medical specialty Neurology. A SESE decision is a clearance finding, not premarket approval of the system.
The reviewed documents describe the ISIS Neurostimulator as an evoked-response stimulator with 12 channels for high-current stimulation and one channel for low-current stimulation, and describe the systems as supplied pre-configured as medical systems. The documents also reference evoked potentials, EEG and intraoperative monitoring functions. The source data do not state which components changed relative to the predicate, the predicate device, or any clinical performance data, so those points remain unknown.
The record shows a submission date of 08/28/2026 and a decision date of 09/24/2026, with the applicant listed at Im Hausgruen 29, Emmendingen, Germany. No indications, patient-selection criteria or treatment parameters are established here; those would reside in the original FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263010
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- inomed Medizintechnik GmbH
- Product code
- GWF
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Electrical, Evoked Response.
- Applicant
- inomed Medizintechnik GmbH
- Product code
- GWF
- FDA device class
- 2
FDA decision timeline
K263010 received
Application receipt date recorded by FDA.
K263010 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
inomed Medizintechnik GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Emmendingen
Sources and methodology
- Original FDA record: K263010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records